HDAC9 and carcinoma: For instance, pan-HDAC inhibitors exhibited synergistic effects when combined with 5-FU in CRC cell lines in vitro or with FOLFOX or FOLFIRI in CRC carcinomas in a preclinical study, thus showing a potential role for HDAC inhibitors as chemosensitizers [165,166].